Xiaomin Liu Selected Research

ErbB Receptors (EGF Receptor)

1/2023	Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance.
1/2022	EGFR, NF-κB and noncoding RNAs in precision medicine.
1/2019	Cryptotanshinone Suppresses Non-Small Cell Lung Cancer via microRNA-146a-5p/EGFR Axis.
4/2018	Effects of combined radiosurgery and temozolomide therapy on epidermal growth factor receptor and variant III in glioblastoma multiforme.
8/2017	MicroRNA-107-5p suppresses non-small cell lung cancer by directly targeting oncogene epidermal growth factor receptor.
7/2017	Epidermal growth factor receptor (EGFR): A rising star in the era of precision medicine of lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaomin Liu Research Topics

Disease

64	Neoplasms (Cancer) 03/2024 - 05/2010
19	Carcinogenesis 01/2024 - 12/2010
10	Lung Neoplasms (Lung Cancer) 02/2024 - 07/2014
9	Infections 04/2024 - 06/2013
9	Type 2 Diabetes Mellitus (MODY) 01/2022 - 07/2007
8	Inflammation (Inflammations) 04/2022 - 02/2016
7	Glioblastoma (Glioblastoma Multiforme) 03/2024 - 04/2012
7	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 07/2016
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 08/2017
6	Glioma (Gliomas) 01/2024 - 12/2010
5	Neoplasm Metastasis (Metastasis) 12/2023 - 12/2012
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 03/2013
3	Prostatic Neoplasms (Prostate Cancer) 02/2024 - 01/2023
3	Autoimmune Diseases (Autoimmune Disease) 09/2023 - 02/2019
3	Reperfusion Injury 02/2023 - 12/2014
3	Hypoxia (Hypoxemia) 01/2023 - 01/2016
3	Cataract (Cataracts) 12/2022 - 08/2019
3	Stroke (Strokes) 11/2022 - 04/2021
3	Wounds and Injuries (Trauma) 01/2022 - 06/2006
3	Infarction (Infarctions) 12/2021 - 01/2016
3	Disease Progression 10/2021 - 06/2013
3	Thrombosis (Thrombus) 10/2021 - 01/2010
3	COVID-19 01/2021 - 05/2020
3	Ovarian Neoplasms (Ovarian Cancer) 01/2019 - 08/2015
2	Chronic Hepatitis B 02/2024 - 01/2022
2	Breast Neoplasms (Breast Cancer) 12/2023 - 10/2023
2	Rheumatoid Arthritis 02/2023 - 01/2023
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 02/2023 - 01/2016
2	Brain Ischemia (Cerebral Ischemia) 02/2023 - 10/2015
2	Ischemic Stroke 11/2022 - 01/2022
2	Lung Diseases (Lung Disease) 05/2022 - 03/2013
2	Disease Resistance 05/2022 - 01/2020
2	Pain (Aches) 01/2022 - 03/2018
2	Hyperglycemia 01/2022 - 12/2014
2	Atherosclerosis 01/2022 - 02/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 06/2013
2	Obesity 01/2022 - 01/2021
2	Myocardial Infarction 11/2021 - 06/2013
2	Body Weight (Weight, Body) 10/2021 - 04/2014
2	Neuromyelitis Optica (Devic's Disease) 03/2021 - 06/2020
2	Thyroid Neoplasms (Thyroid Cancer) 01/2021 - 04/2017
2	Ischemia 12/2020 - 01/2020
2	Proteinuria 11/2020 - 10/2012
2	Starvation 01/2020 - 04/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020 - 05/2018

Drug/Important Bio-Agent (IBA)

21	Proteins (Proteins, Gene)FDA Link 04/2024 - 05/2010
14	MicroRNAs (MicroRNA)IBA 05/2022 - 07/2016
10	Biomarkers (Surrogate Marker)IBA 02/2024 - 10/2017
8	Glucose (Dextrose)FDA LinkGeneric 02/2023 - 02/2015
6	Messenger RNA (mRNA)IBA 10/2023 - 03/2003
6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 07/2017
6	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2010
5	Long Noncoding RNAIBA 11/2022 - 01/2016
5	Untranslated RNA (Noncoding RNA)IBA 07/2022 - 07/2017
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2018 - 04/2014
4	Androgen Receptors (Androgen Receptor)IBA 02/2024 - 05/2019
3	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 04/2018
3	Oxygen (Dioxygen)IBA 01/2024 - 01/2016
3	OrexinsIBA 01/2024 - 01/2017
3	Sorafenib (BAY 43-9006)FDA Link 01/2024 - 01/2020
3	LipidsIBA 10/2023 - 03/2021
3	Therapeutic UsesIBA 09/2023 - 01/2022
3	Transcription Factors (Transcription Factor)IBA 01/2023 - 06/2018
3	epidermal growth factor receptor VIIIIBA 01/2023 - 04/2018
3	AntioxidantsIBA 10/2022 - 01/2022
3	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022 - 01/2020
3	CholesterolIBA 01/2022 - 01/2022
3	Peptides (Polypeptides)IBA 05/2018 - 08/2015
2	PolymersIBA 07/2024 - 12/2022
2	Salicylic Acid (2 Hydroxybenzoic Acid)FDA LinkGeneric 04/2024 - 05/2022
2	lenvatinibIBA 01/2024 - 10/2021
2	16S Ribosomal RNAIBA 01/2023 - 01/2022
2	Competitive Endogenous RNAIBA 11/2022 - 01/2016
2	Oxidoreductases (Dehydrogenase)IBA 11/2022 - 01/2017
2	Plant Growth Regulators (Plant Hormones)IBA 10/2022 - 01/2020
2	Dopamine (Intropin)FDA LinkGeneric 05/2022 - 10/2017
2	Bevacizumab (Avastin)FDA Link 01/2022 - 04/2012
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 03/2021
2	Uric Acid (Urate)IBA 01/2022 - 05/2015
2	Tryptophan (L-Tryptophan)FDA Link 01/2022 - 01/2018
2	Triglycerides (Triacylglycerol)IBA 01/2022 - 01/2022
2	EnzymesIBA 12/2021 - 01/2020
2	Troponin IIBA 11/2021 - 01/2021
2	Prealbumin (Transthyretin)IBA 04/2021 - 06/2018
2	Fluorescent Dyes (Fluorescent Probes)IBA 04/2021 - 01/2020
2	Nucleic AcidsIBA 03/2021 - 05/2020
2	GinsenosidesIBA 03/2021 - 01/2020
2	Indicators and Reagents (Reagents)IBA 01/2021 - 12/2019
2	Gefitinib (Iressa)FDA Link 01/2020 - 10/2019
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020 - 12/2014

Therapy/Procedure

29	Therapeutics 07/2024 - 08/2012
6	Immunotherapy 01/2024 - 11/2021
6	Photochemotherapy (Photodynamic Therapy) 01/2019 - 05/2012
4	Radiotherapy 12/2023 - 07/2012
3	Drug Therapy (Chemotherapy) 01/2023 - 04/2012
3	Precision Medicine 01/2022 - 07/2017
2	Castration 02/2024 - 01/2023
2	Aftercare (After-Treatment) 01/2024 - 01/2018
2	Fecal Microbiota Transplantation 09/2023 - 08/2018
2	Percutaneous Coronary Intervention 12/2021 - 06/2013